ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Beam Therapeutics Inc

Beam Therapeutics Inc (BEAM)

24,23
-0,83
(-3,31%)
Geschlossen 15 März 9:00PM
24,11
-0,12
(-0,50%)
Nach Börsenschluss: 12:55AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
24,11
Gebot
24,10
Fragen
24,50
Volumen
2.166.267
23,94 Tagesbereich 25,805
20,84 52-Wochen-Bereich 37,42
Marktkapitalisierung
Handelsende
25,06
Handelsbeginn
25,55
Letzte Trade
1
@
24.5
Letzter Handelszeitpunkt
Finanzvolumen
US$ 53.168.612
VWAP
24,5439
Durchschnittliches Volumen (3 Mio.)
1.511.773
Ausgegebene Aktien
83.688.295
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,39
Gewinn pro Aktie (EPS)
-4,5
Erlöse
63,52M
Nettogewinn
-376,7M

Über Beam Therapeutics Inc

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio co... Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Beam Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker BEAM. The last closing price for Beam Therapeutics was US$25,06. Over the last year, Beam Therapeutics shares have traded in a share price range of US$ 20,84 to US$ 37,42.

Beam Therapeutics currently has 83.688.295 shares in issue. The market capitalisation of Beam Therapeutics is US$2,10 billion. Beam Therapeutics has a price to earnings ratio (PE ratio) of -5.39.

BEAM Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-2.78-10.338415767926.8929.0524.03386488726.32022864CS
4-5.14-17.572649572629.2535.2523.63228734828.17389202CS
12-2.79-10.371747211926.935.2522.5151177327.27945231CS
26-2.28-8.6396362258426.3935.2521.135127286326.43055123CS
52-12.95-34.943335132237.0637.4220.84123628026.30242873CS
156-36.12-59.970114560960.2373.2716.95114663033.57719083CS
2608.1150.687516138.52191397410545.06051701CS

BEAM - Frequently Asked Questions (FAQ)

What is the current Beam Therapeutics share price?
The current share price of Beam Therapeutics is US$ 24,11
How many Beam Therapeutics shares are in issue?
Beam Therapeutics has 83.688.295 shares in issue
What is the market cap of Beam Therapeutics?
The market capitalisation of Beam Therapeutics is USD 2,1B
What is the 1 year trading range for Beam Therapeutics share price?
Beam Therapeutics has traded in the range of US$ 20,84 to US$ 37,42 during the past year
What is the PE ratio of Beam Therapeutics?
The price to earnings ratio of Beam Therapeutics is -5,39
What is the cash to sales ratio of Beam Therapeutics?
The cash to sales ratio of Beam Therapeutics is 31,94
What is the reporting currency for Beam Therapeutics?
Beam Therapeutics reports financial results in USD
What is the latest annual turnover for Beam Therapeutics?
The latest annual turnover of Beam Therapeutics is USD 63,52M
What is the latest annual profit for Beam Therapeutics?
The latest annual profit of Beam Therapeutics is USD -376,7M
What is the registered address of Beam Therapeutics?
The registered address for Beam Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Beam Therapeutics website address?
The website address for Beam Therapeutics is www.beamtx.com
Which industry sector does Beam Therapeutics operate in?
Beam Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen